CCL-2 and CXCL-8: Potential Prognostic Biomarkers of Acute Kidney Injury after a Bothrops atrox Snakebite

• Published in: Mediators of inflammation Vol. 2022; pp. 8285084 - 14
• Main Authors: Neves, Juliana Costa Ferreira, Ibiapina, Hiochelson Najibe Santos, Magalhães-Gama, Fábio, Sachett, Jacqueline Almeida Gonçalves, Silva, Iran Mendonça, Coelho, Kerolaine Fonseca, Alves, Eliane Campos, Tarragô, Andréa Monteiro, de Lima Ferreira, Luiz Carlos, Malheiro, Adriana, Monteiro, Wuelton Marcelo, Costa, Allyson Guimarães
• Format: Journal Article
• Language: English
• Published: United States Hindawi 07-09-2022; John Wiley & Sons, Inc; Hindawi Limited
• Subjects: Acute Kidney Injury; Analysis; Animals; Antivenins - therapeutic use; Antivenom; Biological markers; Biomarkers; Bites and stings; Blood & organ donations; Bothrops; Bothrops atrox; Chemokines; Creatinine; Cytokines; Enzymes; Ethylenediaminetetraacetic acid; Immunology; Inflammation; Interleukin 10; Interleukin 2; Interleukin 4; Interleukin 6; Interleukin-17; Kidneys; Medical research; Medicine, Experimental; Pathogenesis; Patients; Peripheral blood; Prognosis; Snake bites; Snake Bites - complications; Snakes; Software; Tumor necrosis factor; Venom; γ-Interferon; Brazil; United States > US
• ISSN: 0962-9351; 1466-1861; 1466-1861
• DOI: 10.1155/2022/8285084

In the Brazilian Amazon, the snake Bothrops atrox is the primary cause of snakebites. B. atrox (BaV) venom can cause systemic pathophysiological changes such as acute kidney injury (AKI), which leads to the production of chemokines and cytokines in response to the envenomation. These soluble immunological molecules act by modulating the inflammatory response; however, the mechanisms associated with the development of AKI are still poorly understood. Here, we characterize the profile of these soluble immunological molecules as possible predictive biomarkers of the development of AKI. The study involved 34 patients who had been victims of snakebites by Bothrops sp. These were categorized into two groups according to the development of AKI (AKI(-)/AKI(+)), using healthy donors as the control (HD). Peripheral blood samples were collected at three-time points: before antivenom administration (T0) and at 24 and 48 hours after antivenom (T1 and T2, respectively). The soluble immunological molecules (CXCL-8, CCL-5, CXCL-9, CCL-2, CXCL-10, IL-6, TNF, IL-2, IL-10, IFN-γ, IL-4, and IL-17A) were quantified using cytometric bead array. Our results demonstrated an increase in CXCL-9, CXCL-10, IL-6, IL-2, IL-10, and IL-17A molecules in the groups of patients who suffered Bothrops snakebites (AKI(-) and AKI(+)) before antivenom administration, when compared to HD. In the AKI(+) group, levels of CXCL-8 and CCL-2 molecules were elevated on admission and progressively decreased during the clinical evolution of patients after antivenom administration. In addition, in the signature analysis, these were produced exclusively by the group AKI(+) at T0. Thus, these chemokines may be related to the initiation and extension of AKI after envenomation by Bothrops and present themselves as two potential biomarkers of AKI at T0.